Within a fraction of the typical manufacturing timeline, VGXI has manufactured and released a vaccine for human clinical testing. We are proud to be a part of the global effort to address the COVID-19 pandemic.

THE WOODLANDS, Texas (PRWEB)
April 06, 2020

VGXI, an industry leading provider of GMP grade plasmid DNA for vaccines and gene therapies, announced it has completed manufacturing and release of a DNA vaccine to combat the COVID-19 pandemic. VGXI was selected by Inovio Pharmaceuticals in late January to produce the vaccine under a $9 million grant to Inovio from the Coalition for Epidemic Preparedness Innovations (CEPI). Rapid mobilization of efforts across both companies enabled a record-setting timeline to release and initiation of clinical testing for the novel DNA vaccine within just 2 months from the start of production and only 3 months from public release of the virus genetic sequence. The large scale manufacturing campaign has supplied thousands of vaccine doses up to 4 times faster than traditional plasmid DNA production would support.

As of today, nearly 1,300,000 cases of COVID-19 have been identified worldwide, with about 70,000 deaths. In the US, there have been over 330,000 cases and nearly 10,000 deaths. Travel, commerce, and daily life is disrupted around the world as countries implement policies to slow the spread of the virus. In parallel with these efforts, the race to make a safe, effective vaccine widely available is essential to overcoming the current crisis.

“The dedicated team at VGXI has worked tirelessly to meet this challenge,” stated VGXI CEO Mr. Young Park. “Within a fraction of the typical manufacturing timeline, VGXI has manufactured and released a vaccine for human clinical testing. We are proud to be a part of the global effort to address the COVID-19 pandemic.”

With the Phase 1 trial beginning in the US, the vaccine developer and VGXI client for the last 13 years, Inovio Pharmaceuticals, is also coordinating simultaneous clinical trials in China and South Korea. Additional large scale manufacturing of the vaccine at the VGXI facility has already been scheduled in 2Q 2020. Mr. Rob Juba, VP of Biological Manufacturing and Clinical Supply Management at Inovio Pharmaceuticals said, “We are delighted to be working with our long term manufacturing partner VGXI to expedite manufacture of our COVID-19 vaccine candidate INO-4800 and enable rapid clinical testing.”

ABOUT VGXI, INC.

As a leading provider of plasmid DNA manufacturing and development services, VGXI, Inc. has proven its ability to support urgent vaccine development timelines in response to past outbreaks such as Ebola, Zika, and other coronaviruses including Middle East Respiratory Syndrome (MERS). The company has a reputation of success in manufacturing DNA products under cGMP conditions for clinical trials in the US, EU, Asia, Canada, and Australia, and its cGMP and non-GMP products have passed rigorous reviews by several international regulatory agencies. VGXI’s ability to work with unique requirements and create custom manufacturing solutions is based on its patented manufacturing process, flexible cGMP production facility, and experienced development team. VGXI, Inc. is a wholly-owned subsidiary CDMO of GeneOne Life Science, Inc. To learn more, visit https://www.vgxii.com.

ABOUT GENEONE LIFE SCIENCE

GeneOne Life Science Inc. (“GeneOne” KOSPI: 011000) is an international DNA vaccine and product developer, and leading contract manufacturer of DNA plasmid-based agents for pre-clinical and clinical trials for global companies and institutions. It researches and develops DNA vaccines and products to prevent and treat incurable diseases in South Korea and internationally. The company is headquartered in Seoul, South Korea. VGXI, Inc., GeneOne’s wholly-owned subsidiary located in Texas, is a leading cGMP DNA plasmid manufacturing facility. For more information, visit http://www.genels.com.

CAUTIONARY FACTORS THAT MAY AFFECT FUTURE RESULTS

Materials in this press release contain information that includes or is based upon forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements relate to expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” and other words and terms of similar meaning in connection with a discussion of potential future events, circumstances or future operating or financial performance. In particular, these include statements relating to future actions, prospective products or product approvals, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. Any or all of our forward-looking statements here or in other publications may turn out to be incorrect. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining our actual future results. Consequently, no forward-looking statement can be guaranteed, and forward-looking statements may be adversely affected by factors, including general market conditions, competitive product development, product availability, current and future branded and generic competition, federal and state regulations and legislation, manufacturing issues, timing of the elimination of trade buying, patent positions, litigations and investigations. Our actual results may vary materially, and there are no guarantees about the performance or valuation of GeneOne stock. It is also important to read the disclosure notice contained in many of the individual GeneOne documents available on the website, as many contain important information on such cautionary factors as of the date of the individual document. We undertake no obligation to correct or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports.

Share article on social media or email:

We understand the struggles that come along with conceiving, so we decided to bundle all of our reproductive supplements together to make it easier for parents to start trying.

LOS ANGELES (PRWEB)
April 06, 2020

Eu Natural, a leading wellness brand that creates plant-powered formulas to meet your body’s needs, is excited to announce FERTILITY, the ultimate supplement bundle for male and female reproductive health.

According to the Centers for Disease Control and Prevention (CDC), about 6% of married women aged 15 to 44 years in the United States are unable to get pregnant after one year of trying with an additional 12% of women in the same age range having difficulty getting pregnant or carrying a pregnancy to term, regardless of marital status. Eu Natural is aligned with the notion that fertility challenges can be experienced by anyone, regardless of race, religion, sexuality or economic status.

“For parents looking for noninvasive measures to support pregnancy health, our FERTILITY bundle is a great place to start,” said Vinay Amin, founder of Eu Natural. “We understand the struggles that come along with conceiving, so we decided to bundle all of our reproductive supplements together to make it easier for parents to start trying. The supplements give partners the support they need for optimum reproductive health and contain nothing but 100% pure, wholesome vitamins, minerals, and herbs with zero additives or fillers.”

The bundle includes CONCEPTION, a multi-vitamin for mom and baby’s future, including Vitamin D, zinc, iron, DHA, and folate folic acid. CONCEPTION MEN contains a full spectrum of vitamins and Pygeum Extract that work in concert to rapidly support sperm count. N-Acetyl Cysteine (NAC), Ashwagandha and Folate provide a gradual but potent boost to male fertility. The MOMMA supplement is a powerful probiotic, which promotes digestive, immune, and vaginal health.

Additionally, with every purchase of an Eu Natural supplement, they donate via their charity partner, Vitamin Angels, one year of vitamins for children under five, new mothers, and pregnant women who are at risk for malnutrition.

“Eu Natural’s partnership with Vitamin Angels truly shows their commitment to making this world a healthier place,” said Howard Schiffer, Vitamin Angels Founder and President. “As their business grows, they are helping even more at-risk mothers and babies around the world receive life-changing vitamins and minerals.”

In 2019, Vitamin Angels was able to distribute vitamins to approximately 70 million children residing in more than 74 countries.

About Eu Natural

Eu Natural was founded in 2013 to empower its customers and their health, creating powerful blends of herbs, vitamins, and minerals, each formulated to promote the best in health. The wellness brand’s premium health supplements are made in the USA and follow Good Manufacturing Practices. They are made without any extra fillers, binders or artificial ingredients. Eu Natural uses only the purest and most potent natural ingredients. To learn more about Eu Natural and its supplements, visit https://store.eunatural.com.

Share article on social media or email:

Charles E. Crutchfield III, M.D.

In these unprecedented times, we are fortunate to be able to help and feel honored to serve all those with dermatologic needs, including those who can’t afford it.” said Charles E. Crutchfield III, M.D., Medical Director of CrutchfieldDermatology.com

EAGAN, Minn. (PRWEB)
April 06, 2020

Dr. Crutchfield realizes that there are many people without insurance or who have recently lost their insurance and still need dermatologic care. As a result, Crutchfield Dermatology is offering 40 telemedicine/teledermatology visits every month, at no charge, for those who need it.

During a pandemic, other human health issues don’t disappear. In fact, if additional medical clinics close or have limited availability, patients suffering from many different medical ailments will be forced to take up valuable appointment spots in urgent care centers, emergency rooms, and even hospitals. That is why it is so essential to maintain a robust telemedicine capability to free up the burden and stress that could potentially burden those other healthcare facilities so they can focus on providing care for those who urgently need it.

At Crutchfield Dermatology, we have conducted nearly 300 telemedicine (teledermatology) visits in the past two weeks. Per capita, per dermatologist, this leads the nation. The schedulers at Crutchfield report excellent results as patients are happy to sign up for virtual online teledermatology visits. Patients love the ability to get their skincare needs addressed without having to go to urgent care. They can do so from the comfort, safety, and convenience of their own home. “Patients give the teledermatology visits very high ratings.” Commented Ashley N., lead nursing staff member.

Minnesota Governor Walz recently wrote a letter jointly with the Commissioners of Health and Commerce, urging health plans in Minnesota to extend coverage for most Minnesotans to receive medical care remotely – known as “telemedicine.” Other state leaders praised the effort as consistent with legislation aimed at expanding remote care. “Crutchfield Dermatology was ahead of the curve on this one and are seeing patients who need it, without charge,” commented Tim Quesnell, Clinic General Manager.

When it comes to online virtual telemedicine visits, we are incredibly flexible. Crutchfield Dermatology utilizes several telemedicine platforms including, but not limited to, Zoom, Skype, FaceTime, Google Duo, WhatsApp, GoToMeeting, Slack cell phones, and even emailed photos combined with landlines. As a result, Crutchfield Dermatology can now serve about 95% of all patients who need an online virtual dermatology appointment.

Another positive is that most skin conditions are very amenable to telemedicine. Dr. Crutchfield can see the problem right on the monitor. With the quality of most computer cameras and cell phones, the picture quality is outstanding. For the few visits where there is a suspicious lesion, the doctor can have the patients come into the clinic, with full safety precautions. In urgent cases, the clinic can handle acute medical needs, in-person, also. “In fact, we have detected three melanoma’s via teledermatology over the past two weeks.” reports Dr. Crutchfield

In these unprecedented times, we are fortunate to be able to help and feel honored to serve all those with dermatologic needs, including those who can’t afford it.” said Charles E. Crutchfield III, M.D., Medical Director of CrutchfieldDermatology.com

All they have to do is call our gratis telemedicine coordinator, Kelly M., at 651 209 3628, and she will take it from there.

About Charles E. Crutchfield III, M.D.:

Charles E. Crutchfield III, M.D. is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He currently is the Medical Director of Crutchfield Dermatology in Eagan, (serving the greater Minneapolis-St. Paul area), Minnesota. Dr. Crutchfield is an annual selection of the “Top Doctors” issue of Mpls. St. Paul magazine. He is the only dermatologist to have been selected as a “Best Doctor for Women” by Minnesota Monthly magazine since the inception of the survey. Dr. Crutchfield has been selected as one of the “Best Doctors in America,” an honor awarded to only 4% of all practicing physicians. Dr. Crutchfield is the co-author of a children’s book on sun protection and dermatology textbook. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. Dr. Crutchfield was also given “first a physician” award, Healthcare Hero, 100 most influential healthcare leaders in Minnesota, and one of the Top 100 African –American Newsmakers in the United States by TheGrio, an affiliate of NBC News. https://en.wikipedia.org/wiki/Grio_Awards

Share article on social media or email:

Law Offices of Blumenthal Nordrehaug Bhowmik De Blouw LLP

For more information about the class action lawsuit against Hy-Lang Electric California, Inc., or if you would like to know if you qualify to make a claim, please contact attorney Nicholas J. De Blouw today by calling (800) 568-8020.

SAN DIEGO (PRWEB)
April 06, 2020

The San Diego labor law attorneys at Blumenthal Nordrehaug Bhowmik De Blouw LLP filed a class action lawsuit against Hy-Lang Electric California, Inc., alleging the company failed to pay accurate wages, failed to provide required meal and rest breaks, and was in violation of the Private Attorneys General Act. The Hy-Lang Electric California, Inc. lawsuit, Case No. 37-2020-00012543-CU-OE-CTL, is currently pending in the San Diego County Superior Court for the State of California. A copy of the complaint can be accessed by clicking here.

According to the class action complaint’s allegations, Hy-Lang Electric California, Inc. failed and continues to fail to accurately calculate and pay PLAINTIFF and the other members of the CALIFORNIA CLASS for their overtime worked. DEFENDANT also failed to record and pay employees for the actual amount of time worked, meaning the time during which an employee was subject to the control of an employer. Additionally, as a result of their rigorous work schedules, PLAINTIFF and other CALIFORNIA CLASS Members were from time to time unable to take of duty meal breaks and were not fully relieved of duty for meal periods. The lawsuit also alleges DEFENDANT failed to reimburse for required business expenses incurred by PLAINTIFF. Under California Labor Code Section 2801, employers are required to indemnify employees for all expenses incurred in the course and scope of their employment.

PAGA is a mechanism by which the State of California itself can enforce state labor laws through the employee suing under the PAGA who do so as the proxy or agent of the state’s labor law enforcement agencies. An action to recover civil penalties under PAGA is fundamentally a law enforcement action designed to protect the public and not to benefit private parties. The purpose of PAGA is not to recover damages or restitution, but to create a means of “deputizing” citizens as private attorneys general to enforce the Labor Code.

For more information about the class action lawsuit against Hy-Lang Electric California, Inc., or if you would like to know if you qualify to make a claim, please contact attorney Nicholas J. De Blouw today by calling (800) 568-8020.

Blumenthal Nordrehaug Bhowmik De Blouw LLP is a labor law firm with law offices located in San Diego County, Riverside County, Los Angeles County, Sacramento County, and San Francisco County. The firm has a statewide practice of representing employees on a contingency basis for violations involving unpaid wages, overtime pay, discrimination, harassment, wrongful termination and other types of illegal workplace conduct.

***THIS IS AN ATTORNEY ADVERTISEMENT***

Share article on social media or email:

Surge Alumni sharing their stories on why your donations are so important for their work.

“Take a moment to give, no matter the amount. Take a moment to share with as many people as you can. And please take a moment to be in connection and community with those who need your love and support.” – Surge Founder Carmita Semaan and Board President Darryl Cobb

CHICAGO (PRWEB)
April 06, 2020

The Surge Institute, a national nonprofit organization that develops and connects emerging leaders of color in education, has launched a new fundraising campaign to support its fellows and alumni in their efforts to serve youth and communities impacted by the COVID-19 pandemic.

The organization launched the Surge Relief Fund on April 1, 2020, sharing the stories of several fellows and alumni who have had their work in youth service, teacher support, mentorship, and community resource distribution heavily stifled by the virus and shelter in place restrictions it has caused. 

Among the Surge Alumni impacted is Andrea Black, principal of Schmid Elementary on the South Side of Chicago. “Several of my families do not have access to things like a chromebook, a tablet, an iPad, so that they can connect virtually to their teachers,” Black shared in a video message. “Your donation can allow that to happen.”

Also affected is Randal Seriguchi, Jr., Executive Director of Urban Ed Academy, whose mission is to see at least one man of color teaching in every elementary school in San Francisco. “In the midst of a global pandemic, like other nonprofits, we’re finding ourselves battling food insecurity and a digital divide,” Seriguchi said. “We’re dealing with the conversion to virtual classrooms, to virtual professional development opportunities . . . It’s a scramble to make sure we continue to support those most vulnerable.”

Through the new relief fund, Surge seeks to provide support to all of its fellows and alums who are directly serving communities heavily impacted by COVID-19, who are the most in need. 

 

The Surge Institute has established a webpage with more information about the campaign, including frequently asked questions and video testimonials from fellows and alumni. The fundraising effort will carry through the entire month, ending on April 30, 2020. Surge will distribute 100 percent of the funds to fellows and alumni on May 15, 2020.

In a heartfelt message from Surge Founder Carmita Semaan and Board President Darryl Cobb, the organization asked for donations and support. “Please be a trailblazer for this effort,” Semaan and Cobb stated in the letter. “Take a moment to give, no matter the amount. Take a moment to share with as many people as you can. And please take a moment to be in connection and community with those who need your love and support.”

Share article on social media or email:

The joy of singing is so important for health and wellness and has a magical way of lessening the emotional toll of self-isolation

NEW YORK (PRWEB)
April 06, 2020

In honor of Parkinson’s Awareness Month, the full month of April, the World Parkinson Coalition (WPC) is holding its first ever virtual Parkinson’s Sing-A-Long led by WPC Choir Director, Judi Spencer. Past members of the WPC Choir who performed at the 4th and 5th World Parkinson Congresses will come together with up to 500 other members of the global Parkinson’s community on four occasions to sing together in April.

The WPC hosts the most unique international scientific conference in the Parkinson’s space. Every three years the WPC brings together basic scientists, neurologists, general physicians, nurses, rehab specialists, clinicians, as well as people with Parkinson’s (PwP) and their care partners to learn about Parkinson’s, build collaborations, and expand our understanding of a disease that impacts more than 10 million people worldwide.

“While the World Parkinson Congress is a scientific meeting, creativity plays a unique role in the overall program,” said Elizabeth Pollard, WPC Executive Director. “Each WPC offers a variety of creative endeavors to complement the science and research. We believe that by weaving creativity into one’s wellness plan, individuals can have a better quality of life. Not only do artistic endeavors help exercise the mind, they bring great joy to the artist and to those around the artist.”

Many people with Parkinson’s experience symptoms that impact their speaking and swallowing. The weakening of the muscles in the throat can cause people with Parkinson’s to experience loss of voice, decreased ability to project their voice and may lead to swallowing and respiratory complications. While all people with Parkinson’s are encouraged to work with a Speech Language Pathologist from the day of diagnosis, there are many fun things that patients can do on their own to support the voice training they receive, such as joining a choir and engaging in regular singing activities.

The WPC Parkinson’s Sing-A-Long is a way to support the global Parkinson’s community by encouraging them to continue to use and exercise their voices even while self-isolating due to COVID-19. Registration and details can be found at https://wpc2022.org/choir

Parkinson’s Sing-A-Long Dates

Thursday, April 9, 2020 at 5PM ET

Thursday, April 16, 2020 at 1PM ET

Thursday, April 23, 2020 at 5PM ET

Thursday, April 30, 2020 at 1PM ET

“Leading the WPC Choir has always brought me such joy,” said choir director, Judi Spencer of Seattle, Washington, USA. “I always look forward to the choir coming together at each World Parkinson Congress, and am pleased we can bring them together virtually in this way. The joy of singing is so important for health and wellness and has a magical way of lessening the emotional toll of self-isolation.”

Learn more about the Parkinson’s Sing-Along and WPC Choir at https://wpc2022.org/page/choir

About the World Parkinson Coalition® and WPC 2022

The World Parkinson Coalition Inc. provides an international forum for learning about the latest scientific discoveries, medical practices, caregiver initiatives and advocacy work related to Parkinson’s disease. The triennial World Parkinson Congresses provide a space for the global Parkinson’s community of researchers, clinicians, health care professionals, people with Parkinson’s and their care partners to meet in person, network, and discuss advances in Parkinson’s research, improve understanding and promote advocacy worldwide, while influencing future research and care options. The WPC 2022 will attract more than 4,500 delegates.

About Parkinson’s Disease

Affecting nearly one million Americans and 10 million people worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s. There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the United States alone.

Share article on social media or email:

OB2me Care provider seeing a patient

Receive Board Certified Prenatal and Gynecological Care In Your Home

MARIETTA, Ga. (PRWEB)
April 06, 2020

Healthcare has taken a sudden and dramatic turn these last few weeks, and doctor’s offices across the world are having to close or accept the risk of spreading the COVID-19 virus in their offices. Many OB/GYN offices that have remained open are not allowing expectant moms’ partners to attend their prenatal visits with them. Hospitals are also determined to decrease exposure risk by restricting support people for laboring woman to one person for their entire hospital admission.

From the patient’s perspective, it’s a tough decision: They can either seek prenatal or gynecological care and risk becoming infected with COVID-19, or NOT seek these essential services and risk their baby’s health or their own health.

Thankfully, there’s a new service being offered through OB2me that enables women to get the care they need without putting them and their babies at undo risk and without the need to change doctors.

OB2me provides prenatal and GYN visits in the comfort and safety of women’s homes. Our provider will send a visit summary report to her primary OB/GYN care provider after each visit, so while using OB2me, she won’t need to switch providers. OB2me’s services are offered at a flat fee, paid per visit, with no obligation to continue services.

Also, NO ONE wants to RISK going to the hospital unnecessarily during this COVID-19 pandemic. So in addition to providing standard prenatal visits, on April 1st OB2me began offering in-home triage services for expectant women who may be unsure if it’s time to go to the hospital to deliver. The Ob2me provider will go to the expectant mother’s home and provide a thorough labor check to help them decide if it really is time to go to the hospital. This will prevent unnecessary risky and expensive hospital admissions for false alarms and help the mother stay home with their support system in the early phases of labor.

Share article on social media or email:

“Our mission at Bug Busters is to work with our customers & communities to provide innovative approaches to achieve a pest free property while protecting the environments in which we all live and work, adding disinfection services is essential to our mission,” says Court Parker, CEO Bug Busters, Inc

ATLANTA (PRWEB)
April 06, 2020

Bug Busters, Inc. announces that it has been offering critical disinfection services to commercial & residential clients in our service area of Georgia to help combat the spread of the COVID-19 virus. Bug Busters mission is highlighted by four underline components “Customer Service…Development…Community Involvement…Technology.” Never did we foresee a future where all four parts of our mission would be so necessary in the way it is now with the current COVID-19 crisis.

First things first: our team, customers, and vendors are all part of our family and they mean the world to us. Doing our part in this uncertain time is vital to our mission and company culture. At Bug Busters, that means utilizing technology to work remotely & communicate with our team to help mitigate the spread of the virus. Secondly, continue with customer service through our part of Public Health, while being cautious with non-essential person to person contact. Thirdly, community involvement with the development of a new services to stop the spread of germs with a professional disinfectant treatment.

As of March 20,2020 we have been offering a Disinfectant service with Nisus DSV. We have worked for the last several days to develop this new service for our community to help combat the spread of COVID-19. The disinfection service can be performed in a wide range of commercial venues including warehouses, distribution facilities, processing facilities, schools, office buildings, gyms, public buildings, and residential homes.

For more information on Bug Busters, Inc. disinfection services, visit https://bugbustersusa.com/nisus-dsv/ or call 678-752-9700.

Share article on social media or email: